ISMAEL
BUÑO BORDE
Profesor asociado
CARLOS JAVIER
ANGUITA VELASCO
Profesor asociado de Ciencias de la Salud
Publications by the researcher in collaboration with CARLOS JAVIER ANGUITA VELASCO (27)
2024
-
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients
Transplantation and Cellular Therapy, Vol. 30, Núm. 3, pp. 306.e1-306.e12
-
Identification of predictive models including polymorphisms in cytokines genes and clinical variables associated with post-transplant complications after identical HLA-allogeneic stem cell transplantation
Frontiers in Immunology, Vol. 15
2023
-
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide
Annals of Hematology, Vol. 102, Núm. 6, pp. 1561-1567
2022
-
Allogeneic CD34-selected stem cell boost as salvage treatment of life-threatening infection and severe cytopenias after CAR-T cell therapy
Transfusion, Vol. 62, Núm. 10, pp. 2143-2147
-
Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation
Frontiers in immunology, Vol. 13, pp. 1002959
-
FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia
Cancers, Vol. 14, Núm. 16
2021
-
Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide
Frontiers in Immunology, Vol. 12
-
Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide
Frontiers in Immunology, Vol. 12
-
Genetic biomarkers identify a subgroup of high-risk patients within low-risk NPM1-mutated acute myeloid leukemia
Leukemia and Lymphoma, Vol. 62, Núm. 5, pp. 1178-1186
-
Next generation cytogenetics in myeloid hematological neoplasms: Detection of cnvs and translocations
Cancers, Vol. 13, Núm. 12
-
Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation
Annals of Hematology, Vol. 100, Núm. 2, pp. 541-553
2019
-
Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders
AIDS, Vol. 33, Núm. 9, pp. 1441-1447
-
Next-generation sequencing improves diagnosis, prognosis and clinical management of myeloid neoplasms
Cancers, Vol. 11, Núm. 9
-
Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation
Blood Advances, Vol. 3, Núm. 21, pp. 3351-3359
-
ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide
Frontiers in Immunology, Vol. 10
-
Successful Treatment of Severe Aspergillosis with Isavuconazole Therapy after Allogeneic Stem Cell Transplantation
Chemotherapy, Vol. 64, Núm. 2, pp. 57-61
2017
-
Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML
Bone Marrow Transplantation, Vol. 52, Núm. 8, pp. 1138-1143
-
Transient hemolysis due to anti-D and anti-A1 produced by engrafted donor's lymphocytes after allogeneic unmanipulated haploidentical hematopoietic stem cell transplantation
Transfusion, Vol. 57, Núm. 10, pp. 2355-2358
2016
-
Inhibitory killer cell immunoglobulin-like receptor (iKIR) mismatches improve survival after T-cell-repleted haploidentical transplantation
European Journal of Haematology, Vol. 96, Núm. 5, pp. 483-491
2015
-
Achievement of early complete donor chimerism in CD25+-activated leukocytes is a strong predictor of the development of graft-versus-host-disease after stem cell transplantation
Experimental Hematology, Vol. 43, Núm. 1, pp. 4-13